Palatin Technologies Announces Reacquisition of Full Rights to ... CNNMoney.com - "Regarding the FSD program with bremelanotide, we have completed an exploratory at-home Phase 2 clinical trial in pre- and postmenopausal women and are in ... |
For more information, please visit
http://money.cnn.com/news/newsfeeds/arti[...]910092007-1.htm&cid=1120576843